首页> 外国专利> METHOD FOR DIFFERENTIATING DEGENERATIVE STEM CELL TO MESENCHYMAL STEM CELL THROUGH SINGLE CELL CULTURING BY USING p38-INHIBITOR TREATMENT

METHOD FOR DIFFERENTIATING DEGENERATIVE STEM CELL TO MESENCHYMAL STEM CELL THROUGH SINGLE CELL CULTURING BY USING p38-INHIBITOR TREATMENT

机译:p38抑制剂治疗通过单细胞培养将变性干细胞分化为间充质干细胞的方法

摘要

The present invention relates to a method for degenerative stem cells to mesenchymal stem cells through single-cell culturing with a p38-inhibitor treatment. According to the present invention, the cells generated through a temporary p38-inhibitor treatment process in the process of differentiating mesenchymal stem cells from degenerative stem cells by using a direct differentiation scheme are checked to be mesenchymal stem cells by a property analysis including morphological properties, surface markers, and multi-differentiability. The cells have colony forming ability, differentiation functions, and especially the efficiency of differentiation into chondrocytes significantly higher than mesenchymal stem cells derived from umbilical cord blood. Accordingly, the method for differentiating the mesenchymal stem cells from degenerative stem cells can be used for development of mesenchymal stem cell lines with higher functionality.;COPYRIGHT KIPO 2017
机译:本发明涉及通过用p38抑制剂处理的单细胞培养将变性干细胞转化为间充质干细胞的方法。根据本发明,在通过使用直接分化方案使间充质干细胞与变性干细胞分化的过程中,通过临时的p38抑制剂处理过程产生的细胞通过包括形态学特性在内的特性分析被检查为间充质干细胞,表面标记和多分化性。该细胞具有集落形成能力,分化功能,尤其是分化成软骨细胞的效率明显高于源自脐带血的间充质干细胞。因此,用于区分间充质干细胞和变性干细胞的方法可用于开发功能性更高的间充质干细胞系。; COPYRIGHT KIPO 2017

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号